- Markets
- Healthcare
- HINDBIO
HINDBIO
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Hindustan Bio Sciences Names Jaison George As CFO
Oct 31 (Reuters) - Hindustan Bio Sciences Ltd HISO.BO:
NAMES JAISON GEORGE AS CFO
Source text for Eikon: ID:nBSEbt5VZp
Further company coverage: HISO.BO
(([email protected];))
Oct 31 (Reuters) - Hindustan Bio Sciences Ltd HISO.BO:
NAMES JAISON GEORGE AS CFO
Source text for Eikon: ID:nBSEbt5VZp
Further company coverage: HISO.BO
(([email protected];))
Hindustan Bio Sciences Says Gali Seshavataram Resigns As CFO
Sept 4 (Reuters) - Hindustan Bio Sciences Ltd HISO.BO:
GALI SESHAVATARAM RESIGNS AS CFO
Source text for Eikon: ID:nBSE1YnPdl
Further company coverage: HISO.BO
(([email protected];))
Sept 4 (Reuters) - Hindustan Bio Sciences Ltd HISO.BO:
GALI SESHAVATARAM RESIGNS AS CFO
Source text for Eikon: ID:nBSE1YnPdl
Further company coverage: HISO.BO
(([email protected];))
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Hind Bio Science do?
Hindustan Bio Sciences Limited is a public limited company established in 1991, specializing in the manufacturing and sale of pharmaceutical products.
Who are the competitors of Hind Bio Science?
Hind Bio Science major competitors are Ortin Global, iStreet Network, Cian Healthcare, Senbo Industries, Secunderabad Health., Unjha Formulations, Kobo Biotech. Market Cap of Hind Bio Science is ₹9 Crs. While the median market cap of its peers are ₹8 Crs.
Is Hind Bio Science financially stable compared to its competitors?
Hind Bio Science seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Hind Bio Science pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Hind Bio Science latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Hind Bio Science allocated its funds?
Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Short Term Loans & Advances
How strong is Hind Bio Science balance sheet?
Hind Bio Science balance sheet is weak and might have solvency issues
Is the profitablity of Hind Bio Science improving?
Yes, profit is increasing. The profit of Hind Bio Science is ₹0.06 Crs for Mar 2024, -₹0.04 Crs for Mar 2023 and -₹0.52 Crs for Mar 2022
Is the debt of Hind Bio Science increasing or decreasing?
The debt of Hind Bio Science is decreasing. Latest debt of Hind Bio Science is ₹2.15 Crs as of Sep-24. This is less than Mar-24 when it was ₹2.49 Crs.
Is Hind Bio Science stock expensive?
Yes, Hind Bio Science is expensive. Latest PE of Hind Bio Science is 279, while 3 year average PE is 53.18. Also latest EV/EBITDA of Hind Bio Science is 484 while 3yr average is 192.
Has the share price of Hind Bio Science grown faster than its competition?
Hind Bio Science has given better returns compared to its competitors. Hind Bio Science has grown at ~18.56% over the last 3yrs while peers have grown at a median rate of 17.5%
Is the promoter bullish about Hind Bio Science?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Hind Bio Science is 12.19% and last quarter promoter holding is 12.19%.
Are mutual funds buying/selling Hind Bio Science?
There is Insufficient data to gauge this.